Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0311277 (
abdominal obesity
)
2,792
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previous reports have shown that the Asp358Ala (T/G) polymorphism of the
interleukin 6 receptor
(
IL6R
) gene is associated with obesity and type 2 diabetes mellitus, but few studies have examined this association in the Japanese population. We performed the current study to investigate the relationship between the
IL6R
Asp358Ala (T/G) polymorphism and obesity in healthy Japanese men. Two hundred eighty-five healthy Japanese men (age, 46.1 +/- 11.5 years [mean +/- SD]; waist circumference [WC], 83.9 +/- 9.3 cm; body mass index, 23.3 +/- 3.3 kg/m(2)) employed by a Japanese company were enrolled in this study. Height, weight, and WC were measured, and daily energy intake levels were assessed by self-reported questionnaires. Genotyping of polymorphisms was performed by using melting curve analysis; no association was found between
IL6R
genotype and WC or body mass index. However, when the subjects were stratified by
IL6R
genotype, an association between WC and dietary energy intake level was found in the TT + GT-type subjects (P for linear regression = .048), but not in GG subjects (P for linear regression = .555). In addition, logistic regression analysis revealed that the interaction of
IL6R
(GG vs TT + GT) genotypes and dietary energy intake levels affected risk for
abdominal obesity
(P for interaction = .030). We concluded that the
IL6R
Asp358Ala (T/G) polymorphism appears to interact with energy intake and affect
abdominal obesity
in Japanese men. The interaction of this genotype and energy intake warrants further study.
...
PMID:The interaction between the interleukin 6 receptor gene genotype and dietary energy intake on abdominal obesity in Japanese men. 1757 Feb 54